What over-the-counter options are available for an adult with depression-related loss of libido and comorbid attention-deficit/hyperactivity disorder who prefers to avoid prescription mood medications?

Over-the-Counter Options for Depression

For an adult with depression who wishes to avoid prescription medications, St. John's wort is the only over-the-counter option with evidence showing comparable efficacy to prescription antidepressants, though it comes with significant safety concerns and is not FDA-regulated in the United States. 1

Evidence for St. John's Wort

Low-quality evidence demonstrates that St. John's wort may be as effective as second-generation antidepressants (SGAs) for treating major depressive disorder, and moderate-quality evidence shows it was better tolerated than SGAs with fewer discontinuations due to adverse events 1. The 2023 American College of Physicians systematic review identified St. John's wort among complementary and alternative medicine (CAM) interventions with supporting evidence 2.

Critical Safety Warnings

However, St. John's wort carries serious limitations that make it problematic as a first-line recommendation:

• Not FDA-regulated: No quality control standards exist for contents or potency in the United States, meaning patients cannot reliably obtain preparations with similar effectiveness to those studied 1

• Dangerous drug interactions: St. John's wort induces cytochrome P450 isoenzyme 3A4, which can reduce the bioavailability or efficacy of:

  • Oral contraceptives (critical for this patient)
  • Immunosuppressants
  • Many other medications 1

• Contraindicated combinations: Absolutely cannot be used with monoamine oxidase inhibitors or serotonin reuptake inhibitors 1

Other OTC Options Lack Direct Evidence

The 2023 ACP guideline mentions other CAM interventions including omega-3 fatty acids, S-adenosyl-L-methionine (SAMe), acupuncture, and meditation 2. However, none of these have the same level of evidence as St. John's wort for treating major depressive disorder, and the guidelines do not provide specific efficacy data for these as monotherapies.

Special Considerations for This Patient

Given the context of comorbid ADHD and sexual dysfunction concerns:

• Loss of libido: If this patient were to use prescription antidepressants, bupropion is associated with lower rates of sexual adverse events compared to SSRIs like fluoxetine, sertraline, and particularly paroxetine 1, 3. This is relevant because St. John's wort's mechanism may still affect sexual function, though data are limited.

• ADHD comorbidity: The patient's ADHD requires separate consideration. While bupropion can address both depression and ADHD symptoms 4, this is a prescription option. No OTC options have evidence for treating ADHD 5, 6.

Strongest Recommendation Based on Guidelines

The American College of Physicians 2016 guideline (reaffirmed in 2024) makes a strong recommendation that clinicians select between cognitive behavioral therapy (CBT) or second-generation antidepressants for major depressive disorder 1, 7. This is based on moderate-quality evidence showing similar effectiveness, but CBT has fewer adverse effects and lower relapse rates.

Therefore, the evidence-based answer is: CBT should be the first-line treatment for this patient who wishes to avoid prescription medications, not an OTC supplement. CBT is similarly effective to antidepressants, has no drug interactions, addresses the psychological aspects of depression, and may help with organizational skills relevant to ADHD 1.

Clinical Algorithm

1. First choice: Refer for cognitive behavioral therapy (evidence-based, no drug interactions, addresses both mood and potentially some executive function issues)

2. If patient insists on OTC supplement: St. John's wort could be considered ONLY if:

   • Patient is not taking oral contraceptives or other interacting medications
   • Patient understands lack of FDA regulation and quality control concerns
   • Patient can obtain a reputable European preparation
   • Close monitoring is arranged

3. If sexual dysfunction is primary concern: This strongly argues for either CBT alone or eventual consideration of prescription bupropion rather than SSRIs, as sexual side effects are common with serotonergic antidepressants 1, 3

4. ADHD management: Requires separate evaluation and likely prescription treatment, as no OTC options have supporting evidence 5, 4

Common Pitfalls to Avoid

• Do not assume OTC means safe: St. John's wort has serious drug interactions that can lead to treatment failures (contraceptive failure, transplant rejection, etc.)
• Do not delay effective treatment: Depression with comorbid ADHD significantly impairs quality of life; pursuing ineffective OTC options delays evidence-based care
• Do not ignore the sexual dysfunction: This may be depression-related rather than treatment-related, and choosing the wrong antidepressant later could worsen it 3, 8

Bottom line: While St. John's wort is the only OTC option with evidence, CBT is the superior non-pharmacologic choice that aligns with both the patient's preference to avoid prescription medications and the highest-quality guideline recommendations.